Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells.

He, Cong; Jaffar Ali, Doulathunnisa; Li, Yumin; Zhu, Yanliang; Sun, Bo; Xiao, Zhongdang

He, Cong; Jaffar Ali, Doulathunnisa; Li, Yumin; Zhu, Yanliang; Sun, Bo; Xiao, Zhongdang.

Afiliación

He C; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, China.
Jaffar Ali D; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, China.
Li Y; Key Laboratory for Developmental Genes and Human Disease, Ministry of Education, Institute of Life Sciences, Jiangsu Province High-Tech Key Laboratory for Bio-Medical Research, Southeast University, Nanjing, Jiangsu, China.
Zhu Y; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, China.
Sun B; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, China.
Xiao Z; State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, China.

PeerJ ; 8: e9524, 2020.

Article en En | MEDLINE | ID: mdl-33062407

Palabras clave

Exosomes; GPC3; HEK-293; HN3; HuH-7; Sorafenib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PeerJ Año: 2020 Tipo del documento: Article País de afiliación: China